Related Experiment Videos
[In vitro binding of p53 and telomeric repeat factor 2]
Ling Li1, Bo Zhang, Wan-Zhong Zou
1Department of Pathology, Health Science Center, Peking University, Beijing 100083, China. lingli@bjmu.edu.cn
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|April 22, 2005
Summary
The tumor suppressor p53 directly binds to Telomeric Repeat Factor 2 (TRF2) via its C-terminus. This interaction, crucial for telomere regulation, involves specific binding regions on p53.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The p53 protein is a critical tumor suppressor involved in cellular responses to DNA damage.
- Telomeres, the protective caps at the ends of chromosomes, are maintained by proteins like Telomeric Repeat Factor 2 (TRF2).
- Understanding the interplay between p53 and telomere-associated proteins is key to deciphering cancer development and regulation.
Purpose of the Study:
- To investigate the molecular interaction between the tumor suppressor p53 and Telomeric Repeat Factor 2 (TRF2).
- To elucidate the role of the telomere pathway in regulating p53 activity.
- To identify the specific binding domains involved in the p53-TRF2 interaction in vitro.
Main Methods:
- Purification of wild-type and mutant p53-GST fusion proteins.
- In vitro pull-down assays using purified p53 proteins and MCF-7 cell extracts.
- Western blot analysis to detect the interaction between p53 and TRF2.
Main Results:
- Direct binding between wild-type p53 and TRF2 was confirmed.
- The C-terminus of p53 (amino acids 293-393) was identified as the critical region for TRF2 interaction.
- Truncation of the p53 C-terminus significantly reduced binding, while N-terminal truncation enhanced it.
Conclusions:
- p53 directly and specifically interacts with TRF2 in vitro.
- The C-terminal region of p53 is essential for this interaction.
- This p53-TRF2 interaction may play a role in cellular responses to telomere alterations.